Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing drotrecogin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drotrecogin alfa 5 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drotrecogin alfa 20mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drotrecogin alfa 20 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drotrecogin alfa 20 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing drotrecogin alfa in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only drotrecogin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drotrecogin alfa only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drotrecogin alfa 5 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drotrecogin alfa 5 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Drotrecogin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |